Spots Global Cancer Trial Database for hormone therapy
Every month we try and update this database with for hormone therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device | NCT04116827 | Sleep Disorder Breast Cancer | Tamoxifen Oral ... | 18 Years - 45 Years | Samsung Medical Center | |
| Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy | NCT04915508 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Hormone Therapy Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer | NCT04794075 | Neoplasm of Bre... | Therapeutic Edu... | 18 Years - 75 Years | Centre Hospitalier Emile Roux | |
| Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis | NCT03401034 | Breast Cancer Breast Cancer M... Breast Cancer S... Postmenopausal ... Lifestyle Genetic Factors Inflammation Inflammatory Bi... Hormone Therapy Phytoestrogens | 50 Years - 74 Years | German Cancer Research Center | ||
| Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer | NCT02408536 | Low-grade Serou... Recurrent Invas... | 18 Years - | National Cancer Institute, Naples | ||
| Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | NCT00108290 | Prostate Cancer | Chemotherapy | 18 Years - 80 Years | VA Office of Research and Development | |
| Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer | NCT04619069 | Prostate Cancer | SBRT Hormone therapy | 18 Years - | Sunnybrook Health Sciences Centre | |
| A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients. | NCT05585476 | Female Urogenit... Breast Cancer F... | C02 microablati... Regenerative to... | 18 Years - 100 Years | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | |
| A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. | NCT05717166 | Metastatic Tumo... | Palliative Radi... Chemotherapy Hormone therapy Immunotherapy Targeted System... Observation Stereotactic Ab... Surgery Radiofrequency ... Fractionated Ra... | 18 Years - | Lawson Health Research Institute | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Androgen Deprivation Therapy Study | NCT00743327 | Hypogonadism Metabolic Syndr... Diabetes Inflammation | Pioglitazone | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer | NCT00080613 | Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | exemestane adjuvant therap... aromatase inhib... conventional su... endocrine thera... hormone therapy neoadjuvant the... surgery | - | National Cancer Institute (NCI) | |
| Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration | NCT00878436 | Prostate Cancer Prostatic Neopl... | Panobinostat Bicalutamide | 18 Years - | NYU Langone Health | |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | NCT00227773 | Gastrointestina... Islet Cell Carc... | octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer | NCT05690295 | Breast Cancer S... Postmenopause Resistance Trai... | Prolonged resis... | 45 Years - 59 Years | Universidad de La Frontera | |
| RADAR Trial - Randomised Androgen Deprivation and Radiotherapy | NCT00193856 | Prostate Cancer | Leuprorelin Ace... Zoledronic Acid Conventional ex... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | NCT05617885 | Metastatic Pros... Non-metastatic ... Prostate Cancer | Darolutamide Abemaciclib GNRH-A Leuproli... GNRH-A Gosereli... Degarelix | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | NCT00148772 | Prostate Cancer | Erlotinib (Tarc... | 18 Years - | NorthShore University HealthSystem | |
| Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration | NCT00878436 | Prostate Cancer Prostatic Neopl... | Panobinostat Bicalutamide | 18 Years - | NYU Langone Health | |
| DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment | NCT06075953 | Ductal Carcinom... | Tamoxifen Exemestane Letrozole Anastrazole Testosterone + ... Elacestrant Z-endoxifen | 18 Years - | QuantumLeap Healthcare Collaborative | |
| Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index | NCT01701050 | Metastatic Brea... | Blood collectio... | 18 Years - | Janssen Diagnostics, LLC | |
| Androgen Deprivation Therapy Study | NCT00743327 | Hypogonadism Metabolic Syndr... Diabetes Inflammation | Pioglitazone | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer | NCT03493854 | Early Breast Ca... | Cyclophosphamid... Doxorubicin Docetaxel Paclitaxel Pertuzumab IV FDC of Pertuzum... Trastuzumab IV Trastuzumab SC Surgery Post-operative ... Hormone Therapy | 18 Years - | Hoffmann-La Roche | |
| The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer | NCT01023802 | Neoadjuvant The... Chemotherapy Hormone Replace... Breast Cancer | 18 Years - | Mayo Clinic | ||
| Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer | NCT04794075 | Neoplasm of Bre... | Therapeutic Edu... | 18 Years - 75 Years | Centre Hospitalier Emile Roux | |
| Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | NCT00148772 | Prostate Cancer | Erlotinib (Tarc... | 18 Years - | NorthShore University HealthSystem | |
| Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer | NCT02408536 | Low-grade Serou... Recurrent Invas... | 18 Years - | National Cancer Institute, Naples | ||
| Investigating the Impact of Tamoxifen Therapy on Ovarian Aging | NCT01384526 | Breast Cancer Fertility | 25 Years - | University of California, San Francisco | ||
| Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer | NCT05448547 | Prostate Cancer | Radiotherapy or... initial observa... Hormone therapy | 75 Years - | The Hospital of Vestfold | |
| Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer | NCT00660803 | Breast Cancer | Fulvestrant | 18 Years - | AstraZeneca | |
| Culturally Aware AET Non-Initiation Intervention | NCT05465408 | Breast Cancer Survivorship Treatment Compl... Treatment Adher... Treatment Refus... | Culturally Awar... | 18 Years - | Massachusetts General Hospital | |
| Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer | NCT02366130 | Breast Cancer | Ra-223 dichlori... Denosumab Hormone Therapy | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality | NCT06415162 | Breast Cancer | Cooling Pillowc... | 18 Years - | Saglik Bilimleri Universitesi | |
| Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer | NCT01612871 | Breast Cancer | Tamoxifen, Letr... | 18 Years - | Institut Claudius Regaud | |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | NCT00003517 | Adenocarcinoma ... Stage III Prost... Stage IV Prosta... Recurrent Prost... | antineoplaston ... antineoplaston ... bicalutamide flutamide leuprolide acet... alternative pro... antiandrogen th... biological ther... biologically ba... cancer preventi... complementary a... differentiation... endocrine thera... hormone therapy | 18 Years - | National Cancer Institute (NCI) | |
| CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach) | NCT00681122 | Breast Cancer | 18 Years - | AstraZeneca | ||
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer | NCT01431391 | Prostatic Neopl... Prostate Cancer Prostatic Adeno... | sipuleucel-T leuprolide acet... | 18 Years - | Dendreon | |
| A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer | NCT03493854 | Early Breast Ca... | Cyclophosphamid... Doxorubicin Docetaxel Paclitaxel Pertuzumab IV FDC of Pertuzum... Trastuzumab IV Trastuzumab SC Surgery Post-operative ... Hormone Therapy | 18 Years - | Hoffmann-La Roche | |
| Cognition in the Study of Tamoxifen and Raloxifene | NCT00687102 | Cognition Aging | tamoxifen raloxifene | 65 Years - | Wake Forest University Health Sciences | |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer | NCT04024462 | HER2-positive E... | Pertuzumab IV Trastuzumab IV Pertuzumab and ... Doxorubicin Cyclophosphamid... Docetaxel Surgery Post-Operative ... Hormone Therapy | 18 Years - | Hoffmann-La Roche | |
| Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00044291 | Breast Neoplasm... Neoplasms, Horm... | atamestane toremifene letrozole aromatase inhib... hormone therapy endocrine thera... antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer | NCT04134260 | Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost... | Apalutamide Hormone Therapy Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | NRG Oncology | |
| Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | NCT02494713 | Prostate Cancer | Degarelix Doxorubicin Ketoconazole Docetaxel Estramustine | 18 Years - | The University of Texas Health Science Center, Houston | |
| Mild Cognitive Impairment in Breast Cancer Patients | NCT01949376 | Breast Cancer Cognitive Impai... | 40 Years - 70 Years | Northwestern University | ||
| Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer | NCT01398657 | Prostate Cancer | Adjuvant Androg... | 20 Years - | National Taiwan University Hospital | |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | NCT00227773 | Gastrointestina... Islet Cell Carc... | octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach) | NCT00681122 | Breast Cancer | 18 Years - | AstraZeneca | ||
| Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index | NCT01701050 | Metastatic Brea... | Blood collectio... | 18 Years - | Janssen Diagnostics, LLC | |
| Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy | NCT04915508 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Hormone Therapy Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | NCT01990196 | Prostate Cancer | degarelix enzalutamide trametinib dasatinib | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer | NCT01398657 | Prostate Cancer | Adjuvant Androg... | 20 Years - | National Taiwan University Hospital | |
| Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer | NCT05690295 | Breast Cancer S... Postmenopause Resistance Trai... | Prolonged resis... | 45 Years - 59 Years | Universidad de La Frontera | |
| Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | NCT01990196 | Prostate Cancer | degarelix enzalutamide trametinib dasatinib | 18 Years - | Jonsson Comprehensive Cancer Center | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment | NCT00165399 | Adenocarcinoma ... Prostate Cancer | Docetaxel Estramustine Casodex Zoladex | 18 Years - | Dana-Farber Cancer Institute | |
| Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | NCT00108290 | Prostate Cancer | Chemotherapy | 18 Years - 80 Years | VA Office of Research and Development |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
